Assisted, independent living move-in rates reached record post-pandemic highs in June: NIC
By
Amy Novotney
Sep 07, 2021
Move-ins outpaced move-outs in all three senior living segments — independent living, assisted living, and memory care — for four consecutive months from March through June of this year, showing continued...
Symptom presentation varies by SARS-CoV-2 variant
Dec 21, 2021
During the first wave of COVID-19, cough occurred first in the United States, whereas fever occurred first in China.
Periodic fasting tied to less severe COVID-19 outcomes
Jul 28, 2022
However, no association was seen between periodic fasting and COVID-19 diagnosis.
COVID-19 vaccines prevent hospitalizations in high-risk populations
Sep 16, 2021
Vaccine effectiveness was 81 to 95% for adults aged 85 years and older, those with chronic medical conditions, and Black or Hispanic adults.
Spike RBD IgG antibodies persist after SARS-CoV-2 infection
Jul 13, 2022
Antibody levels were higher for children versus adults across all follow-up time points up to 10 months after infection.
Circulation of respiratory viruses low during COVID-19 pandemic
Jul 23, 2021
Influenza activity decreased in March 2020 and remained low through May 2021. A decrease was seen in other viruses, with no increase until spring 2021.
Antibody response prolonged with COVID-19 vaccine-associated symptoms
Mar 20, 2023
An increased likelihood of experiencing a prolonged neutralizing antibody response was seen for those with vaccine-associated symptoms and prior SARS-CoV-2 infection.
CDC changes mask rules for fully vaccinated people using public transportation
Jun 14, 2021
The agency said the new policy applies to ‘airplanes, trains, subways, buses, taxis, ride-shares, maritime transportation, trolleys, and cable cars.’
Hospital mortality from non-SARS-CoV-2 causes up among seniors
Mar 17, 2022
During the pandemic, mortality in the 30 days after hospital admission for non-SARS-CoV-2 causes increased for Medicare beneficiaries.
Sotrovimab may prevent progression to severe COVID-19
Mar 18, 2022
The risk for all-cause hospitalization or death through day 29 was reduced with sotrovimab versus placebo for circulating variants at the time of the study.